| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Standard Template Labs | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $49M | Series Seed-2 | 3/17/2026 | $39M | $289.95M | $2.05 | ICONIQ Capital, CRV | ||||
 | Svelte Medical Systems | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $153.65M | Series C | 4/23/2021 | $11.89M | $396.2M | $321.83 | Undisclosed Investors | ||||
 | Tango Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $166.88M | Series B-1 | 8/17/2020 | $51.18M | $305.79M | $1.89 | Casdin Capital, Boxer Capital, Cormorant Asset Management, Gilead Sciences | ||||
 | TaskEasy | Consumer & Lifestyle E-commerce | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $50.12M | Series C | 10/25/2019 | $26.38M | $86.25M | $2.20 | River Cities Capital, Camber Creek, Moderne Ventures, Grotech Ventures, Access Venture Partners, Delta Electronics | ||||
 | Terminus | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $212.67M | Series D-1 | 6/30/2023 | $17.32M | $94.43M | $12.40 | Undisclosed Investors | ||||
 | Theorycraft | Consumer & Lifestyle Gaming | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $69.95M | Series B | 9/22/2022 | $50M | $381.69M | $13.71 | Makers Fund, New Enterprise Associates, Andreessen Horowitz | ||||
 | ThreatQuotient | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $129.57M | Series C-1 | 4/6/2021 | $17.56M | $138.8M | $3.02 | New Enterprise Associates, Adams Street Partners, Escalate Capital, Blu Venture Investors, Cisco Investments, Gaingels | ||||
 | Tortugas Neuroscience | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $106M | Series A1 | 4/21/2026 | $33.84M | $273.53M | $7.49 | Cure Ventures, The Column Group, AN Venture Partners | ||||
 | Turnout | Fintech Insurance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $53.4M | Series A | 6/11/2026 | $26M | $400M | $40.05 | HighPost Capital, Shine Capital, LGVP, Mangusta Capital, Honeystone Ventures, Omri Casspi | ||||
 | Twill | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $90.83M | Series D | 3/17/2021 | $31M | $409.29M | $8.14 | Deerfield Management Company, Omega Capital Partners, ION Crossover Partners | ||||
 | Vanqua Bio | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $149.15M | Series B | 7/12/2024 | $130M | $333.4M | $4.06 | Omega Funds, OrbiMed, Citadel, Avoro Ventures, Casdin Capital, Pontifax, Eli Lilly and Company, Logos Capital, Osage University Partners | ||||
 | Zipwhip | Enterprise Software Communication & Collaboration Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $104.15M | Series D | 1/18/2019 | $51.5M | $255.89M | $2.95 | Goldman Sachs, OpenView, M12, Voyager Capital | ||||
 | Augmodo | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $58.86M | Series A-4 | 6/30/2026 | $21.17M | $350M | $21.74 | TQ Ventures, Lerer Hippeau, Jefferson River Capital, Arena Holdings, Chemist Warehouse, New Fare, Interlace Ventures, Webb Investment Network | ||||
 | Avail | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $132.86M | Series B | 10/7/2020 | $100M | $300.42M | $1.18 | D1 Capital Partners, 8VC | ||||
 | AZTherapies | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $121.38M | Series C-1 | 8/28/2020 | $35M | $401.38M | $6.75 | Duopharma Biotech Berhad, Spinnaker Capital, ID Fund, DRADS Capital, Wexford Capital, Nextrans-KCLAVIS, Axiom Associates, DEFTA Partners | ||||
 | Bitglass | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $156.51M | Series D | 4/8/2019 | $76M | $476.27M | $7.38 | Quadrille Capital, Future Fund, SingTel Innov8, Norwest Venture Partners, New Enterprise Associates | ||||
 | Chrome River | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $147.47M | Series D | 1/2/2018 | $135M | $327.03M | $48.96 | Great Hill Partners, First Analysis, Argentum Group, Bain Capital Ventures | ||||
 | CommonBond | Fintech Lending | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $52.02M | Series D-1 Prime | 3/21/2018 | $3.75M | $403.8M | $3.03 | Fifth Third Capital Holdings, First Republic Bank, Columbia Seligman Investments, Neuberger Berman, August Capital, Nyca Partners, Vikram Pandit, Tom Glocer | ||||
 | Distil Networks | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $60.4M | Series C | 1/19/2018 | $27.51M | $147.08M | $1.53 | EDBI, Baseline Ventures, Kleiner Perkins Caufield & Byers, TomorrowVentures, Norwest Venture Partners, Venrock, GV, EPIC Ventures, Hewlett Packard Pathfinder, Focus Opportunity Fund, Northern Light Venture Capital | ||||
 | Eden Health | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $98.78M | Series C | 2/18/2021 | $60M | $382.34M | $4.67 | Insight Partners, Amigos Health, Aspect Ventures, Company Ventures, Flare Capital, Flexcap Ventures, Max Ventures, PJC | ||||
 | Factual | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $198.58M | Series B-1 | 9/5/2018 | $37.12M | $240.28M | $6.37 | Upfront Ventures, Felicis Ventures and other undisclosed investors | ||||
 | GenLogs | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $84.42M | Series B | 2/2/2026 | $63.44M | $369.39M | $17.94 | Battery Ventures, IVP, Cathay Innovation, 9Yards, Venrock, Steel Atlas, HOF Capital, TitletownTech, Autotech Ventures | ||||
 | Imperfect Foods | Foodtech Food Products & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $321.35M | Series E | 10/31/2022 | $60.2M | $178.07M | $2.90 | Undisclosed Investors | ||||
 | IsoPlexis | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $161.52M | Series D | 1/7/2021 | $92.5M | $348.21M | $76.92 | Perceptive Advisors, Ally Bridge Group, BlackRock | ||||